These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34138361)

  • 41. Stem Cell-Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy.
    Kamdar F; Das S; Gong W; Klaassen Kamdar A; Meyers TA; Shah P; Ervasti JM; Townsend D; Kamp TJ; Wu JC; Garry MG; Zhang J; Garry DJ
    J Am Coll Cardiol; 2020 Mar; 75(10):1159-1174. PubMed ID: 32164890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
    Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
    BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of duchenne muscular dystrophy.
    De Oliveira Moreira D; Pereira JA; Taniguti AP; Matsumura CY; Ramos LA; Areas MA; Neto HS; Marques MJ
    Muscle Nerve; 2013 Dec; 48(6):911-9. PubMed ID: 23536447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of critical molecular pathways involved in exosome-mediated improvement of cardiac function in a mouse model of muscular dystrophy.
    Su X; Shen Y; Jin Y; Weintraub NL; Tang YL
    Acta Pharmacol Sin; 2021 Apr; 42(4):529-535. PubMed ID: 32601364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.
    Pritchard HAT; Pires PW; Yamasaki E; Thakore P; Earley S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9745-E9752. PubMed ID: 30181262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.
    Dahiya S; Givvimani S; Bhatnagar S; Qipshidze N; Tyagi SC; Kumar A
    J Immunol; 2011 Sep; 187(5):2723-31. PubMed ID: 21810612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in
    Mareedu S; Pachon R; Thilagavathi J; Fefelova N; Balakrishnan R; Niranjan N; Xie LH; Babu GJ
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H200-H210. PubMed ID: 33216625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A long-term treatment with taurine prevents cardiac dysfunction in mdx mice.
    Mele A; Mantuano P; De Bellis M; Rana F; Sanarica F; Conte E; Morgese MG; Bove M; Rolland JF; Capogrosso RF; Pierno S; Camerino GM; Trabace L; De Luca A
    Transl Res; 2019 Feb; 204():82-99. PubMed ID: 30347179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy.
    Hughes MC; Ramos SV; Turnbull PC; Edgett BA; Huber JS; Polidovitch N; Schlattner U; Backx PH; Simpson JA; Perry CGR
    J Physiol; 2020 Apr; 598(7):1377-1392. PubMed ID: 30674086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The heart in Duchenne muscular dystrophy: early detection of contractile performance alteration.
    Wagner S; Knipp S; Weber C; Hein S; Schinkel S; Walther A; Bekeredjian R; Müller OJ; Friedrich O
    J Cell Mol Med; 2012 Dec; 16(12):3028-36. PubMed ID: 22970922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Speckle tracking analysis of the left ventricular anterior wall shows significantly decreased relative radial strain patterns in dystrophin deficient mice after 9 months of age.
    Spurney C; Yu Q; Nagaraju K
    PLoS Curr; 2011 Oct; 3():RRN1273. PubMed ID: 22307449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular phenotype of the
    Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
    Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.
    Wasala NB; Yue Y; Lostal W; Wasala LP; Niranjan N; Hajjar RJ; Babu GJ; Duan D
    Mol Ther; 2020 Mar; 28(3):845-854. PubMed ID: 31981493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
    Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
    Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging.
    Soslow JH; Xu M; Slaughter JC; Stanley M; Crum K; Markham LW; Parra DA
    J Am Soc Echocardiogr; 2016 Oct; 29(10):983-991. PubMed ID: 27544870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
    Capogrosso RF; Mantuano P; Uaesoontrachoon K; Cozzoli A; Giustino A; Dow T; Srinivassane S; Filipovic M; Bell C; Vandermeulen J; Massari AM; De Bellis M; Conte E; Pierno S; Camerino GM; Liantonio A; Nagaraju K; De Luca A
    FASEB J; 2018 Feb; 32(2):1025-1043. PubMed ID: 29097503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.
    Jelinkova S; Sleiman Y; Fojtík P; Aimond F; Finan A; Hugon G; Scheuermann V; Beckerová D; Cazorla O; Vincenti M; Amedro P; Richard S; Jaros J; Dvorak P; Lacampagne A; Carnac G; Rotrekl V; Meli AC
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.